The Federal Trade Commission has begun mailing refund checks to consumers who bought expensive "treatment plans" from Golden Sunrise Nutraceutical, a Porterville, California company the agency accused of falsely claiming its products could treat or cure COVID-19, cancer, and Parkinson's disease. The mailings close out a case the FTC first filed in July 2020.
According to the Federal Trade Commission, 578 consumers who bought Golden Sunrise products between July 2017 and July 2020 are receiving refunds this month, totaling more than $40,700. Eligible claimants who filed paperwork on time are getting a full refund of what they paid; consumers who did not file a claim are instead receiving flat $20 checks. A window for late claims stays open through May 12, 2026.
What did the company claim?
The FTC's case record says Golden Sunrise Nutraceutical and its medical director, Stephen Meis, sold "plans of care" priced from $23,000 to $200,000 that were marketed as scientifically proven ways to treat or cure COVID-19, cancer, and Parkinson's disease. The company's president and CEO, Huu Tieu, was also named as a defendant. The agency's complaint described these as false or unproven health claims, not as verified medical findings.
How the case moved through the FTC
The FTC announced a proposed order in June 2021 barring the defendants from making unsupported health claims. A refund process for affected consumers opened in January 2024, and the agency says checks and an online claims portal went out starting in February 2026, nearly six years after the case was first filed. The FTC's own case page still lists the matter as pending even as refunds reach consumers.
What it means for supplement buyers
Dietary supplements, including the vitamins and sports-nutrition products most readers of this site use, are regulated differently from prescription drugs. The Food and Drug Administration says manufacturers are responsible for ensuring their own products are safe and properly labeled before they reach the market; supplements are not pre-approved to treat, cure, or prevent disease the way prescription drugs are. The Golden Sunrise case turned on that gap: a company's own marketing claims about what a product does are not the same as independent verification, which is what the FTC's years-long enforcement process was built to test.
The size of this refund round is small next to the $23,000-to-$200,000 price tags the FTC says some buyers paid for a single plan of care. Most of the 578 people receiving checks this month are getting the flat $20 payment reserved for consumers who did not file a claim, while only those who submitted documentation on time qualify for a full refund of the price they paid.
This article is informational and is not medical advice. Anyone considering a supplement or treatment plan for a serious health condition should talk to a qualified clinician rather than rely on a manufacturer's claims alone.
For a related fitness perspective, read Does the post-workout anabolic window actually exist?.
For more context, read Core CPI Rose 2.5% Year Over Year in July.
For more context, read Owners' Equivalent Rent Carries 25.8% of the CPI.
For more context, read What FOIA's Nine Exemptions Actually Let an Agency Withhold.